fda warning letters compounded semaglutide november 2025 Last month, the issued 25 to telehealth companies over what it called false or misleading claims about GLP-1 medications. Read more at the link in the comments below What is a 503B outsourcing

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective anti-glycemic and weight-loss medications with a strong safety record

Because the workflow, from intake & async clinician review to prescription & ongoing messaging, was largely identical regardless of condition, Ro and Hims & Hers could go on to replicate it across hair loss, dermatology, and fertility, with ED accounting for ~60% of Ro's revenue as late as 2021 and Hims & Hers growing from $82M revenue in 2019 to $527M by 2022

Dosage and administration: Orally via the drinking water

That also means Teladoc is not the right fit for a patient who specifically wants compounded semaglutide or tirzepatide at a cash-only subscription price